Ledipasvir
id:
ledipasvir-276-1009219
title:
Ledipasvir
text:
Ledipasvir is a drug for the treatment of hepatitis C that was developed by Gilead Sciences. After completing Phase III clinical trials, on February 10, 2014, Gilead filed for U.S. approval of a ledipasvir/sofosbuvir fixed-dose combination tablet for genotype 1 hepatitis C. The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin. Ledipasvir is an inh
brand slug:
wiki
category slug:
encyclopedia
description:
Hepatitis C drug
original url:
https://en.wikipedia.org/wiki/Ledipasvir
date created:
date modified:
2024-01-03T23:39:49Z
main entity:
{"identifier":"Q15409409","url":"https://www.wikidata.org/entity/Q15409409"}
image:
fields total:
13
integrity:
14